To further investigate whether increased NOX4 activity is driving LCN2 expression in astrocytes, we tested the effect of NOX4 specific inhibitor GKT137831 on the expression of LCN2 protein in astrocytes subjected to in vitro ischemia. Here, NOX4 is linked to ischemia.